Background: Lesions of breast has gained more importance worldwide due to increase in mortality and morbidity associated with breast cancer. In India increase in incidence is due to life style changes and use of hormones. Presence of different proliferative lesions adjacent to malignancy in the same breast proves that carcinogenesis of breast is a multistep process. Women with proliferative breast lesions are more prone to develop carcinoma. Knowledge in carcinogenesis of breast will define the high risk group that improves the screening for carcinoma and management Aim: The aim is to study the histopathological types of carcinoma breast and benign proliferative breast lesions in peritumoral area. Materials and Method:This study was a cross-sectional study conducted for a period of 2 years. A total of 85 cases that satisfy the inclusion criteria were included in the present study. Samples were collected in 10% formalin. All the tissue specimens were processed and paraffin embedded. The sections were stained with Hematoxylin and Eosin. Histopathology findings were noted. Results thus obtained was analyzed using SPSS 20.0 version. Statistical analysis was done using Chi square test. Results: Common age group affected was between 51 to 60 years seen in 30(35.3%) cases. Lesions were predominantly seen in right breast 39 (45.9%). Invasive carcinoma breast No Special Type was the most common malignant lesion (85.9%). Non proliferative breast lesion was common in peritumoral area 46(54.1%). Statistical significance was observed between histopathological diagnosis, tumour size, lymph node status and peritumoral benign proliferative breast lesions. Conclusion: Proliferative epithelial lesions are at increased risk of subsequent breast cancer. Non proliferative breast diseases are the most common peritumoral lesion in the present study. Even though the risk of transformation to malignancy is less, careful follow-up with clinical breast examination and annual mammographic screening every 6 to 12 months can identify the changes and further it helps to reduce the occurrence of invasive breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.